@FiercePharma: Why does Sanofi's CEO consider 'patent' a dirty word? Report | Follow @FiercePharma
> Belgium's UCB (UCB.BR) reported better than expected first-half results after sales of new drugs accelerated, offsetting declines in blockbusters now facing generic competition. Report
> Generic drugmaker Mylan has priced $300 million in senior notes due in 2020, to help pay for its $550 million acquisition of Bioniche Pharma Holdings. Story
> Generic drugmakers are fighting back against new moves in Congress to ban pay-for-delay deals with branded drugmakers. News
> Merck had indicated that its vaccine Recombivax would ship in mid-2010 after manufacturing issues disrupted supplies, but now the company indicates the vaccine won't be available at all this year. Article
> Teva Pharmaceutical Industries said Canadian antitrust regulators have cleared the company's acquisition of Ratiopharm, owned by the Merckle family. News
> KV Pharmaceutical sued generics maker Perrigo, alleging patent infringement with plans to make low-cost copies of the drug Gynazole used to treat female yeast infections. Report
Biotech News
@FierceBiotech: Charles River, WuXi call off $1.6B deal. Report | Follow @FierceBiotech
@JohnCFierce: Isis says liver enzymes spike when you lower cholesterol; with statins or mipomersen. Could that fly at FDA? I doubt it. | Follow @JohnCFierce
> Wall Street handicaps Sanofi's looming Genzyme bid. Story
> Isis, Genzyme brace for new round of late-stage cholesterol data. Report
> Cardioxyl gets $15M and positive data on lead program. Article
Biotech IT news
> Informatics app matches biosamples, projects. Report
> CRO lightens RA publishing load via SharePoint. News
> Omnicomm buoyed by e-clinical licensing deals. Report
And Finally... The FDA approved vaccines for the next flu season and recommended vaccination for everyone but small infants. Story